🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA  ·  Read original ↗

Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless the conditions of a Pregnancy Prevention Programme are fulfilled. This follows a review by the MHRA which concluded that the use of…


This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.

Share: 𝕏 Twitter/X 🔗 LinkedIn View on MHRA ↗

More in Respiratory / COPD / Asthma